The impact and effectiveness of pneumococcal vaccination in Scotland for those aged 65 and over during winter 2003/2004
<p>Abstract</p> <p>Background</p> <p>For winter 2003/2004 in Scotland, it was recommended that all those aged 65 and over be eligible to receive 23-valent polysaccharide pneumococcal vaccine (23vPPV), which has been shown to be effective in reducing the risk of invasive...
Main Authors: | Macfarlane Tatania V, Ritchie Lewis D, McMenamin Jim, Weir Amanda, Mooney John D, Simpson Colin R, Ahmed Syed, Robertson Chris, Clarke Stuart C |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-04-01
|
Series: | BMC Infectious Diseases |
Online Access: | http://www.biomedcentral.com/1471-2334/8/53 |
Similar Items
-
The impact and effectiveness of pneumococcal vaccination in Scotland for those aged 65 and over during winter 2003/2004
by: Mooney, John D., et al.
Published: (2008) -
Temporal analysis of invasive pneumococcal clones from Scotland illustrates fluctuations in diversity of serotype and genotype in the absence of pneumococcal conjugate vaccine
by: Jefferies, J.M, et al.
Published: (2010) -
Pneumococci causing invasive disease in children prior to the introduction of pneumococcal conjugate vaccine in Scotland
by: Clarke, Stuart C., et al.
Published: (2006) -
Modelling the impact of vaccination and competition on pneumococcal carriage and disease in Scotland
by: Weir, Amanda
Published: (2009) -
Pneumococcal Pneumonia and Invasive Pneumococcal Disease in Those 65 and Older: Rates of Detection, Risk Factors, Vaccine Effectiveness, Hospitalisation and Mortality
by: Roger E. Thomas
Published: (2021-02-01)